If you can't see this email correctly, click here.
avance logo top image
News in Avance Your Source for Valuation header 3


Valuation at Cost

Do you believe in destiny?

Valuation at cost is a popular method to attribute a value to a project. It has its pros and cons and reveals a lot about the philosophical stance of its proponents.

MORE>


01/04/2014 and 02/04/2014
License Contract and Company Valuation in Excel
Basel - Switzerland

P U B L I C A T I O N S

How To Determine Fair License Terms: No Need For Rules Of Thumb Anymore
Les Nouvelles, Licensing Executive Society

Survey about discount rates in pharma and biotech
Survey of industry professionals by Biostrat and Avance about the discount rates for biotech companies.

Valuation Book

Valuation in Life Sciences 3rd Edition
"Valuation in Life Sciences. A Practical Guide" has become the industry reference book. It has now been released already in its 3rd edition.

Click here to order.



License Contract and Company Valuation:
2-day workshop in Basel

Avance holds a 2-days' workshop on company valuation in Basel (1/2 April, 2014). The first day will cover project and license valuation. On the second day we will touch company valuation with delicate topics like cost of capital, taxes, and Monte Carlo simulations. All topics will be put into practice with a case study in Excel.

Basel Workshop >


ri:val: Negotiate your deals with ri:val

ri:val has evolved from a valuation software to an important negotiation and planning tool. Clients from pharma, biotech, universities, and the investor community use ri:val to

  • Evaluate term sheets,
  • Elaborate counter-offers,
  • Read and interpret benchmark deals,
  • Value the company,
  • Run various clinical scenarios,
  • Define liquidity needs,
  • Plan resource allocation,
  • Compare different strategies.
 MORE >


You can sign up for News in Avance or change your e-mail address here.
[Abmeldelink]
Copyright: Avance, Basel GmbH - Bäumleingasse 2 - CH - 4051 Basel